118 related articles for article (PubMed ID: 32002826)
21. Synthesis and biological evaluation of benzodioxanylpiperazine derivatives as potent serotonin 5-HT(1A) antagonists: the discovery of Lecozotan.
Childers WE; Abou-Gharbia MA; Kelly MG; Andree TH; Harrison BL; Ho DM; Hornby G; Huryn DM; Potestio L; Rosenzweig-Lipson SJ; Schmid J; Smith DL; Sukoff SJ; Zhang G; Schechter LE
J Med Chem; 2005 May; 48(10):3467-70. PubMed ID: 15887953
[TBL] [Abstract][Full Text] [Related]
22. The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist.
Brown CM; MacKinnon AC; Redfern WS; Hicks PE; Kilpatrick AT; Small C; Ramcharan M; Clague RU; Clark RD; MacFarlane CB
Br J Pharmacol; 1993 Feb; 108(2):516-25. PubMed ID: 8095420
[TBL] [Abstract][Full Text] [Related]
23. Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptors.
Franchini S; Battisti UM; Baraldi A; Prandi A; Fossa P; Cichero E; Tait A; Sorbi C; Marucci G; Cilia A; Pirona L; Brasili L
Eur J Med Chem; 2014 Nov; 87():248-66. PubMed ID: 25261823
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α₁- and serotonine 5-HT1A receptors.
Prandi A; Franchini S; Manasieva LI; Fossa P; Cichero E; Marucci G; Buccioni M; Cilia A; Pirona L; Brasili L
J Med Chem; 2012 Jan; 55(1):23-36. PubMed ID: 22145629
[TBL] [Abstract][Full Text] [Related]
25. Actions of roxindole at recombinant human dopamine D2, D3 and D4 and serotonin 5-HT1A, 5-HT1B and 5-HT1D receptors.
Newman-Tancredi A; Cussac D; Audinot V; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):447-53. PubMed ID: 10431754
[TBL] [Abstract][Full Text] [Related]
26. Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in α1-adrenergic and 5-HT1A receptor binding sites recognition.
Bonifazi A; Piergentili A; Del Bello F; Farande Y; Giannella M; Pigini M; Amantini C; Nabissi M; Farfariello V; Santoni G; Poggesi E; Leonardi A; Menegon S; Quaglia W
J Med Chem; 2013 Jan; 56(2):584-8. PubMed ID: 23252794
[TBL] [Abstract][Full Text] [Related]
27. Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.
Quaglia W; Pigini M; Piergentili A; Giannella M; Marucci G; Poggesi E; Leonardi A; Melchiorre C
J Med Chem; 1999 Jul; 42(15):2961-8. PubMed ID: 10425105
[TBL] [Abstract][Full Text] [Related]
28. Alpha 1-adrenoceptor blocking properties of spiroxatrine in rat aorta.
Terrón JA; Ransanz V; Ibarra M; Hong E; Villalón CM
Life Sci; 1992; 51(1):PL1-6. PubMed ID: 1352025
[TBL] [Abstract][Full Text] [Related]
29. 1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.
Franchini S; Prandi A; Baraldi A; Sorbi C; Tait A; Buccioni M; Marucci G; Cilia A; Pirona L; Fossa P; Cichero E; Brasili L
Eur J Med Chem; 2010 Sep; 45(9):3740-51. PubMed ID: 20605276
[TBL] [Abstract][Full Text] [Related]
30. Structure-5-HT receptor affinity relationship in a new group of 7-arylpiperazynylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-amino-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione.
Żmudzki P; Chłoń-Rzepa G; Bojarski AJ; Zygmunt M; Kazek G; Mordyl B; Pawłowski M
Arch Pharm (Weinheim); 2015 Apr; 348(4):229-41. PubMed ID: 25773578
[TBL] [Abstract][Full Text] [Related]
31. Binding of O-alkyl derivatives of serotonin at human 5-HT1D beta receptors.
Glennon RA; Hong SS; Bondarev M; Law H; Dukat M; Rakhi S; Power P; Fan E; Kinneau D; Kamboj R; Teitler M; Herrick-Davis K; Smith C
J Med Chem; 1996 Jan; 39(1):314-22. PubMed ID: 8568822
[TBL] [Abstract][Full Text] [Related]
32. 5-HT1A-agonistic properties of naftopidil, a novel antihypertensive drug.
Borbe HO; Metzenauer P; Szelenyi I
Eur J Pharmacol; 1991 Nov; 205(1):105-7. PubMed ID: 1839829
[TBL] [Abstract][Full Text] [Related]
33. Chemical manipulations on the 1,4-dioxane ring of 5-HT
Del Bello F; Bonifazi A; Giorgioni G; Quaglia W; Amantini C; Morelli MB; Santoni G; Battiti FO; Vistoli G; Cilia A; Piergentili A
Eur J Med Chem; 2019 Apr; 168():461-473. PubMed ID: 30844609
[TBL] [Abstract][Full Text] [Related]
34. 6-Acetyl-5-hydroxy-4,7-dimethylcoumarin derivatives: Design, synthesis, modeling studies, 5-HT
Ostrowska K; Leśniak A; Karczyńska U; Jeleniewicz P; Głuch-Lutwin M; Mordyl B; Siwek A; Trzaskowski B; Sacharczuk M; Bujalska-Zadrożny M
Bioorg Chem; 2020 Jul; 100():103912. PubMed ID: 32388437
[TBL] [Abstract][Full Text] [Related]
35. Structural determinants of 5-HT1A versus 5-HT1D receptor binding site selectivity.
Harrington MA; Sleight AJ; Pitha J; Peroutka SJ
Eur J Pharmacol; 1991 Feb; 194(1):83-90. PubMed ID: 2060596
[TBL] [Abstract][Full Text] [Related]
36. 3-amino-3,4-dihydro-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 2. Synthesis and quantitative structure-activity relationship studies of spiro[pyrrolidine- and piperidine-2,3'(2'H)-benzopyrans].
Comoy C; Marot C; Podona T; Baudin ML; Morin-Allory L; Guillaumet G; Pfeiffer B; Caignard DH; Renard P; Rettori MC; Adam G; Guardiola-Lemaitre B
J Med Chem; 1996 Oct; 39(21):4285-98. PubMed ID: 8863806
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus.
Fiorino F; Severino B; De Angelis F; Perissutti E; Magli E; Frecentese F; Esposito A; Massarelli P; Nencini C; Viti B; Santagada V; Caliendo G
Pharmazie; 2009 Sep; 64(9):555-64. PubMed ID: 19827295
[TBL] [Abstract][Full Text] [Related]
38. New 5-HT
Fiorino F; Magli E; Kędzierska E; Ciano A; Corvino A; Severino B; Perissutti E; Frecentese F; Di Vaio P; Saccone I; Izzo AA; Capasso R; Massarelli P; Rossi I; Orzelska-Gòrka J; Kotlińska JH; Santagada V; Caliendo G
Bioorg Med Chem; 2017 Oct; 25(20):5820-5837. PubMed ID: 28943244
[TBL] [Abstract][Full Text] [Related]
39. The signaling and selectivity of α-adrenoceptor agonists for the human α2A, α2B and α2C-adrenoceptors and comparison with human α1 and β-adrenoceptors.
Proudman RGW; Akinaga J; Baker JG
Pharmacol Res Perspect; 2022 Oct; 10(5):e01003. PubMed ID: 36101495
[TBL] [Abstract][Full Text] [Related]
40. Prejunctional alpha2A-autoreceptors in the human gastric and ileocolic arteries.
Guimarães S; Figueiredo IV; Caramona MM; Moura D; Paiva MQ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):207-11. PubMed ID: 9750006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
